Evidence map›Paper›PMID 38064494›Full record

ArticlePloS one2023

Cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.

Iria Ribeiro Novais, Camila Olegario Coelho, Helymar Costa Machado, Fernanda Surita, Luiz Carlos Zeferino, Diama Bhadra Vale

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Iria Ribeiro NovaisDepartment of Obstetrics and Gynecology, University of Campinas, Campinas, São Paulo, Brazil.ORCID 0009-0007-6019-3229
Camila Olegario CoelhoDepartment of Obstetrics and Gynecology, University of Campinas, Campinas, São Paulo, Brazil.ORCID 0000-0001-5823-3278
Helymar Costa MachadoDepartment of Obstetrics and Gynecology, University of Campinas, Campinas, São Paulo, Brazil.
Fernanda SuritaDepartment of Obstetrics and Gynecology, University of Campinas, Campinas, São Paulo, Brazil.ORCID 0000-0003-4335-0337
Luiz Carlos ZeferinoDepartment of Obstetrics and Gynecology, University of Campinas, Campinas, São Paulo, Brazil.
Diama Bhadra ValeDepartment of Obstetrics and Gynecology, University of Campinas, Campinas, São Paulo, Brazil.ORCID 0000-0003-2423-0225
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndigenous women are vulnerable to cervical cancer. Screening is a strategy to reduce the burden of the disease.

objectiveTo evaluate the prevalence profile of cervical cancer screening cytological results in Brazilian indigenous women by age and frequency of tests compared to non-indigenous women.

methodsA cross-sectional study evaluating the prevalences of screening test results in indigenous women assisted in the Brazilian Amazon from 2007 to 2019 (3,231 tests), compared to non-indigenous women (698,415 tests). The main outcome was the cytological result. Other variables were frequency, age groups, and population. The frequency was categorized as "1st test", the first test performed by the women in their lifetime, or "screening test," tests from women who had previously participated in screening. Analyzes were based on prevalences by age group and population. We used Prevalence Ratios (PR) and 95% Confidence Intervals for risks and linear regression for trends.

resultsData from the 1st test showed a higher prevalence of Low-grade Squamous Intraepithelial Lesion (LSIL) in indigenous women. Peaks were observed in indigenous under 25, 35 to 39, 45 to 49, and 60 to 64. The prevalence of High-grade Squamous Intraepithelial Lesion or more severe (HSIL+) was low in both groups in women younger than 25. The indigenous HSIL+ prevalence curve showed a rapid increase, reaching peaks in women from 25 to 34 years, following a slight decrease and a plateau. In screening tests, HSIL+ was more prevalent in indigenous from 25 to 39 (PR 4.0,2.3;6.8) and 40 to 64 (PR 3.8,1.6;9.0). In indigenous, the PR of HSIL+ results in screening tests over 1st tests showed no screening effect in all age groups. In non-indigenous, there was a significant effect toward protection in the age groups over 25.

conclusionThis screening study of indigenous women from diverse ethnicities showed a higher prevalence of cytological LSIL and HSIl+ than in non-indigenous women. The protective screening effect in reducing HSIL+ prevalence was not observed in indigenous.

Indexed as

Papillomavirus InfectionsSquamous Intraepithelial LesionsUterine Cervical DysplasiaUterine Cervical NeoplasmsBrazilCross-Sectional StudiesEarly Detection of CancerFemaleHumansPapillomaviridaePublic PolicyVaginal Smears

Identifiers

PMID38064494
PMCPMC10707695
OpenAlexW4389475286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.